Analyst Ratings for Cincor Pharma Inc (CINC)

CINC Rating Summary

  |   Expand Research on CINC
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/12/2023 Barclays Leon Wang Downgrade Equalweight
(Overweight)		 31.00
(22.00)		 28.80
(29.06)		 0.9% Details
11/29/2022 Oppenheimer Jay Olson Downgrade Perform
(Outperform)		 N/A
(N/A)		 26.53
(29.06)		 9.54% Details